SCHEMBL26129752

SCHEMBL26129752

CCCCCCCCCCCCCCN(CCCCCCCCCCCCCC)C(CC)CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.41
DNM1 Q05193 4/20 0.41
ALDH1A1 P00352 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CYP2D6 P10635 2/20 0.35
GBA1 P04062 1/20 0.35
SPHK1 Q9NYA1 1/20 0.35
GMNN O75496 1/20 0.35
POLB P06746 1/20 0.35
THPO P40225 1/20 0.35
MTOR P42345 1/20 0.35
BLM P54132 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29059636 1.00 LMNA (0.41) LMNADNM1ALDH1A1TSHRHSD17B10
SCHEMBL11864376 1.00 LMNA (0.41) LMNADNM1ALDH1A1TSHRHSD17B10
SCHEMBL31099214 0.94 LMNA (0.39) LMNADNM1ALDH1A1TSHRHSD17B10
SCHEMBL3101607 0.91 ALDH1A1 (0.39) LMNAALDH1A1TSHRHSD17B10MEN1
SCHEMBL11854938 0.85 LMNA (0.45) LMNADNM1ALDH1A1TSHRHSD17B10
SCHEMBL11189670 0.85 LMNA (0.50) LMNADNM1ALDH1A1TSHRHSD17B10
SCHEMBL27666509 0.83 LMNA (0.41) LMNADNM1ALDH1A1TSHRHSD17B10
SCHEMBL11469168 0.83 LMNA (0.41) LMNADNM1ALDH1A1TSHRHSD17B10
SCHEMBL15013531 0.82 DNM1 (0.44) DNM1TSHRCA12CA1CA2
SCHEMBL3106202 0.81 FDPS (0.39) LMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4371410-A1 ANTIBACTERIAL COMPOSITION Lg Chem, Ltd. (KR) 2024-05-22 EP disclosed
US-20240108001-A1 Antibacterial Composition LG CHEM, LTD. (KR) 2024-04-04 US disclosed
US-20240107999-A1 ANTIBACTERIAL COMPOSITION LG CHEM, LTD. (KR) 2024-04-04 US disclosed
EP-4256960-A1 ANTIBACTERIAL COMPOSITION Lg Chem, Ltd. (KR) 2023-10-11 EP disclosed
WO-2023287191-A1 ANTIBACTERIAL COMPOSITION 주식회사 엘지화학 2023-01-19 WO disclosed
WO-2023287071-A1 ANTIBACTERIAL COMPOSITION 주식회사 엘지화학 2023-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240108001-A1 Antibacterial Composition MRPL21, ACMSD, ACR LMNA 1469/4885DNM1 238/4885ALDH1A1 3404/4885
US-20240107999-A1 ANTIBACTERIAL COMPOSITION AAAS, ALB, MYD88 LMNA 2100/4885DNM1 156/4885ALDH1A1 1288/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.